R Nath, R Glen, W William, C Jan… - Biology of Blood and …, 2011 - bbmt.org ... Successful Engraftment and Reduced Early Mortality in Unrelated Donor (UD) Cord Blood (CB) Stem Cell Transplantation (SCT) Using a Preparative Regimen of Thiotepa, Fludarabine, Melphalan and Rabbit Anti-Thymocyte Globulin (TFM/r-ATG) in Older Adults With a Single ... Cached - All 2 versions
F Li, AD Patterson, CC Hofer, KW Krausz… - Biochemical …, 2011 - Elsevier ThioTEPA, an alkylating agent with anti-tumor activity, has been used as an effective anticancer drug since the 1950s. However, a complete understanding of how its alkylating activity relates to clinical efficacy has not been achieved, the total urinary excretion of thioTEPA and its ... Cited by 1 - Related articles - All 2 versions
S Ganguly, V Jain, CL Divine, O Ajitawi… - Biology of Blood and …, 2011 - bbmt.org ... Bumeltt (Busulphan, Melphalan, and Thiotepa) as a Preparative Regimen Prior to Autologous Stem Cell Transplantation in Patients With Relapsed/Refractory Hodgkin'S Disease Does Not Offer Any Advantage Over More Standard Regimens Like Beam or BEAC. S. Ganguly: ... Cached - All 2 versions
Z Lu, J Jia, L Di, G Song, Y Yuan… - … in bioscience (Elite …, 2011 - ncbi.nlm.nih.gov It has been suggested that breast cancer stem cells (CSCs), which characterized by CD44+CD24-/low, may result in treatment failure in patients with breast cancer. It is possible therefore that that inhibiting such subpopulation might subsequently improve clinical ...
J Yu, LJ DI, GH Song, L Che, HF Jiang… - Beijing da xue xue …, 2011 - ncbi.nlm.nih.gov OBJECTIVE: To evaluate the efficacy and safety of docetaxel plus thiotepa(TXT/TSPA) and docetaxel plus capecitabine(TXT/CAPE) in patients with metastatic breast cancer. METHODS: The patients were randomized to give intravenous TXT 35 mg/m2 on days 1 and 8 plus intravenous ...